Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion type Assertion NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_head.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion wasGeneratedBy ECO_0000203 NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion wasDerivedFrom befree-2016 NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion SIO_000772 24367492 NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion evidence source_evidence_literature NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.